Cargando…

NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea

Obstructive sleep apnea (OSA) associated neurocognitive impairment is mainly caused by chronic intermittent hypoxia (CIH)-triggered neuroinflammation and oxidative stress. Previous study has demonstrated that mitochondrial reactive oxygen species (mtROS) was pivotal for hypoxia-related tissue injury...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xu, Gong, Linjing, Xie, Liang, Gu, Wenyu, Wang, Xinyuan, Liu, Zilong, Li, Shanqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943742/
https://www.ncbi.nlm.nih.gov/pubmed/33717152
http://dx.doi.org/10.3389/fimmu.2021.628168
_version_ 1783662555181350912
author Wu, Xu
Gong, Linjing
Xie, Liang
Gu, Wenyu
Wang, Xinyuan
Liu, Zilong
Li, Shanqun
author_facet Wu, Xu
Gong, Linjing
Xie, Liang
Gu, Wenyu
Wang, Xinyuan
Liu, Zilong
Li, Shanqun
author_sort Wu, Xu
collection PubMed
description Obstructive sleep apnea (OSA) associated neurocognitive impairment is mainly caused by chronic intermittent hypoxia (CIH)-triggered neuroinflammation and oxidative stress. Previous study has demonstrated that mitochondrial reactive oxygen species (mtROS) was pivotal for hypoxia-related tissue injury. As a cytosolic multiprotein complex that participates in various inflammatory and neurodegenerative diseases, NLRP3 inflammasome could be activated by mtROS and thereby affected by the mitochondria-selective autophagy. However, the role of NLRP3 and possible mitophagy mechanism in CIH-elicited neuroinflammation remain to be elucidated. Compared with wild‐type mice, NLRP3 deficiency protected them from CIH-induced neuronal damage, as indicated by the restoration of fear-conditioning test results and amelioration of neuron apoptosis. In addition, NLRP3 knockout mice displayed the mitigated microglia activation that elicited by CIH, concomitantly with elimination of damaged mitochondria and reduction of oxidative stress levels (malondialdehyde and superoxide dismutase). Elevated LC3 and beclin1 expressions were remarkably observed in CIH group. In vitro experiments, intermittent hypoxia (IH) significantly facilitated mitophagy induction and NLRP3 inflammasome activation in microglial (BV2) cells. Moreover, IH enhanced the accumulation of damaged mitochondria, increased mitochondrial depolarization and augmented mtROS release. Consistently, NLRP3 deletion elicited a protective phenotype against IH through enhancement of Parkin-mediated mitophagy. Furthermore, Parkin deletion or pretreated with 3MA (autophagy inhibitor) exacerbated these detrimental actions of IH, which was accompanied with NLRP3 inflammasome activation. These results revealed NLRP3 deficiency acted as a protective promotor through enhancing Parkin-depended mitophagy in CIH-induced neuroinflammation. Thus, NLRP3 gene knockout or pharmacological blockage could be as a potential therapeutic strategy for OSA-associated neurocognitive impairment.
format Online
Article
Text
id pubmed-7943742
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79437422021-03-11 NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea Wu, Xu Gong, Linjing Xie, Liang Gu, Wenyu Wang, Xinyuan Liu, Zilong Li, Shanqun Front Immunol Immunology Obstructive sleep apnea (OSA) associated neurocognitive impairment is mainly caused by chronic intermittent hypoxia (CIH)-triggered neuroinflammation and oxidative stress. Previous study has demonstrated that mitochondrial reactive oxygen species (mtROS) was pivotal for hypoxia-related tissue injury. As a cytosolic multiprotein complex that participates in various inflammatory and neurodegenerative diseases, NLRP3 inflammasome could be activated by mtROS and thereby affected by the mitochondria-selective autophagy. However, the role of NLRP3 and possible mitophagy mechanism in CIH-elicited neuroinflammation remain to be elucidated. Compared with wild‐type mice, NLRP3 deficiency protected them from CIH-induced neuronal damage, as indicated by the restoration of fear-conditioning test results and amelioration of neuron apoptosis. In addition, NLRP3 knockout mice displayed the mitigated microglia activation that elicited by CIH, concomitantly with elimination of damaged mitochondria and reduction of oxidative stress levels (malondialdehyde and superoxide dismutase). Elevated LC3 and beclin1 expressions were remarkably observed in CIH group. In vitro experiments, intermittent hypoxia (IH) significantly facilitated mitophagy induction and NLRP3 inflammasome activation in microglial (BV2) cells. Moreover, IH enhanced the accumulation of damaged mitochondria, increased mitochondrial depolarization and augmented mtROS release. Consistently, NLRP3 deletion elicited a protective phenotype against IH through enhancement of Parkin-mediated mitophagy. Furthermore, Parkin deletion or pretreated with 3MA (autophagy inhibitor) exacerbated these detrimental actions of IH, which was accompanied with NLRP3 inflammasome activation. These results revealed NLRP3 deficiency acted as a protective promotor through enhancing Parkin-depended mitophagy in CIH-induced neuroinflammation. Thus, NLRP3 gene knockout or pharmacological blockage could be as a potential therapeutic strategy for OSA-associated neurocognitive impairment. Frontiers Media S.A. 2021-02-24 /pmc/articles/PMC7943742/ /pubmed/33717152 http://dx.doi.org/10.3389/fimmu.2021.628168 Text en Copyright © 2021 Wu, Gong, Xie, Gu, Wang, Liu and Li http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Wu, Xu
Gong, Linjing
Xie, Liang
Gu, Wenyu
Wang, Xinyuan
Liu, Zilong
Li, Shanqun
NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea
title NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea
title_full NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea
title_fullStr NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea
title_full_unstemmed NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea
title_short NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea
title_sort nlrp3 deficiency protects against intermittent hypoxia-induced neuroinflammation and mitochondrial ros by promoting the pink1-parkin pathway of mitophagy in a murine model of sleep apnea
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943742/
https://www.ncbi.nlm.nih.gov/pubmed/33717152
http://dx.doi.org/10.3389/fimmu.2021.628168
work_keys_str_mv AT wuxu nlrp3deficiencyprotectsagainstintermittenthypoxiainducedneuroinflammationandmitochondrialrosbypromotingthepink1parkinpathwayofmitophagyinamurinemodelofsleepapnea
AT gonglinjing nlrp3deficiencyprotectsagainstintermittenthypoxiainducedneuroinflammationandmitochondrialrosbypromotingthepink1parkinpathwayofmitophagyinamurinemodelofsleepapnea
AT xieliang nlrp3deficiencyprotectsagainstintermittenthypoxiainducedneuroinflammationandmitochondrialrosbypromotingthepink1parkinpathwayofmitophagyinamurinemodelofsleepapnea
AT guwenyu nlrp3deficiencyprotectsagainstintermittenthypoxiainducedneuroinflammationandmitochondrialrosbypromotingthepink1parkinpathwayofmitophagyinamurinemodelofsleepapnea
AT wangxinyuan nlrp3deficiencyprotectsagainstintermittenthypoxiainducedneuroinflammationandmitochondrialrosbypromotingthepink1parkinpathwayofmitophagyinamurinemodelofsleepapnea
AT liuzilong nlrp3deficiencyprotectsagainstintermittenthypoxiainducedneuroinflammationandmitochondrialrosbypromotingthepink1parkinpathwayofmitophagyinamurinemodelofsleepapnea
AT lishanqun nlrp3deficiencyprotectsagainstintermittenthypoxiainducedneuroinflammationandmitochondrialrosbypromotingthepink1parkinpathwayofmitophagyinamurinemodelofsleepapnea